Redwire opened a 30,000‑sq‑ft microgravity R&D hub at Novaparke in Georgetown to host ISS‑linked experiments and pharma partnerships. The site includes a live payload ops center.

Eli Lilly agreed to buy AtaiBeckley for about $2.8B upfront, gaining an intranasal 5‑MeO‑DMT therapy now moving into Phase 3. The deal signals big‑pharma interest in rapid‑acting psychedelic treatments.

An IU-led coalition called IMPACT won NSF Engine backing, unlocking an initial $15M and eligibility for up to $160M to speed bone and joint innovations across Indiana.